Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 3, 1998, Pages 727-731

  Schulteis, Gery ^a,b,c   Yackey, Michael ^a   Risbrough, Victoria ^a   Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anxiety; Elevated plus maze; Morphine; Opiate dependence; Opiate withdrawal; Opiates

Indexed keywords

MORPHINE; NALOXONE; OPIATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN DEPTH STIMULATION; DOSE RESPONSE; DRUG ABUSE; DRUG DEPENDENCE; DRUG WITHDRAWAL; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANXIETY; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; RATS, WISTAR; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0031853379     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00034-3     Document Type: Article

References (30)

1. American Psychiatric Association.: DSM-IV: Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Basso, A. M.; Spina, M.; Rivier, J.; Vale, W.; Gold, L. H.; Koob, G. F.: Corticotropin-releasing factor antagonist attenuates the anxiogenic-like effect during cocaine withdrawal in rats. Soc. Neurosci. Abstr. 23:2147; 1997.
3. Becker, H. C.: Positive relationship between the number of prior ethanol withdrawal episodes and the severity of subsequent withdrawal seizures. Psychopharmacology (Berlin) 116:26-32; 1994.
4. Bhattacharya, S. K.; Chakrabarti, A.; Sandler, M.; Glover, V.: Rat brain monoamine oxidase A and B inhibitory (tribulin) activity during drug withdrawal anxiety. Neurosci. Lett. 199:103-106; 1995.
5. Emmett-Oglesby, M. W.; Harris, C. M.; Lane, J. D.; Lal, H.: Withdrawal from morphine generalizes to a pentylenetetrazol stimulus. Neuropeptides 5:37-40; 1984.
6. Emmett-Oglesby, M. W.; Mathis, D. A.; Moon, R. T. Y.; Lal, H.: Animal models of drug withdrawal symptoms. Psychopharmacology (Berlin) 101:292-309; 1990.
7. File, S. E.: The history of benzodiazepine dependence: A review of animal studies. Neurosci. Biobehav. Rev. 14:135-146; 1990.
8. File, S. E.: The biological basis of anxiety. In: Meltzer, H. Y.; Nerozzi, D., eds. Current practices and future development in the pharmacotherapy of mental disorders. Amsterdam: Excerpta Medica; 1991:159-166.
9. File, S. E.: Recent developments in anxiety, stress, and depression. Pharmacol. Biochem. Behav. 54:3-12; 1996.
10. File, S. E.; Baldwin, H. A.; Aranko, K.: Anxiogenic effects in benzodiazepine withdrawal are linked to the development of tolerance. Brain Res. Bull. 19:607-610; 1987.
11. File, S. E.; Baldwin, H. A.; Hitchcott, P. K.: Flumazenil but not nitrendipine reverses the increased anxiety during ethanol withdrawal in the rat. Psychopharmacology (Berlin) 98:252-264; 1989.
12. File, S. E.; Zharkovsky, A.; Hitchcott, P. K.: Effects of nitrendipine, chlordiazepoxide, flumazenil and baclofen on the increased anxiety resulting from alcohol withdrawal. Prog. Neuropsychopharmacol. Biol. Psychiatry 16:87-93; 1992.
13. Gold, L. H.; Stinus, L.; Inturrisi, C. E.; Koob, G. F.: Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur. J. Pharmacol. 253:45-51; 1994.
14. Grasing, K.; Wang, A.; Schlussman, S.: Behavioral measures of anxiety during opiate withdrawal. Behav. Brain Res. 80:195-201; 1996.
15. Hand, T. H.; Koob, G. F.; Stinus, L.; Le Moal, M.: Aversive properties of opioid receptor blockade: Evidence for exclusively central mediation in naive and morphine-dependent rats. Brain Res. 474:364-368; 1988.
16. Harris, G. C.; Aston-Jones, G.: Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats. Psychopharmacology (Berlin) 113:131-136; 1993.
17. Higgins, G. A.; Sellers, E. M.: Antagonist-precipitated opioid withdrawal in rats: Evidence for dissociations between physical and motivational signs. Pharmacol. Biochem. Behav. 48:1-8; 1994.
18. Lowinson, J. H.; Ruiz, P.; Millman, R. B.; Langrod, J. G.: Substance abuse: A comprehensive textbook. Baltimore: Williams and Wilkins; 1997.
19. Maldonado, R.; Stinus, L.; Koob, G. F.: Neurobiological mechanisms of opiate withdrawal. Georgetown: R. G. Landes; 1996.
20. Mucha, R. F.: Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Brain Res. 418:214-220; 1987.
21. Pellow, S.; Chopin, P.; File, S. E.; Briley, M.: Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14:149-167; 1985.
22. Pellow, S.; File, S. E.: Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24:525-529; 1986.
23. Rassnick, S.; Heinrichs, S. C.; Britton, K. T.; Koob, G. F.: Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 605:25-32; 1993.
24. Schaefer, G. J.; Michael, R. P.: Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal. Pharmacol. Biochem. Behav. 25:1263-1269;1986.
25. Schulteis, G.; Koob, G. F.: Reinforcement processes in opiate addiction: A homeostatic model. Neurochem. Res. 21:1437-1454; 1996.
26. Schulteis, G.; Markou, A.; Cole, M.; Koob, G. F.: Decreased brain reward produced by ethanol withdrawal. Proc. Natl. Acad. Sci. USA 92:5880-5884; 1995.
27. Schulteis, G.; Markou, A.; Gold, L. H.; Stinus, L.; Koob, G. F.: Relative sensitivity to naloxone of multiple indices of opiate withdrawal: A quantitative dose-response analysis. J. Pharmacol. Exp. Ther. 271:1391-1398; 1994.
28. Schulteis, G.; Markou, A.; Yackey, M.; Koob, G. F.: Motivational consequences of naloxone-precipitated opiate withdrawal. NIDA Res. Monogr. 141:90; 1994.
29. Stinus, L.; Le Moal, M.; Koob, G. F.: The nucleus accumbens and amygdala as possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37:767-773; 1990.
30. Yoburn, B. C.; Chen, J.; Huang, T.; Inturrisi, C. E.: Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat. J. Pharmacol. Exp. Ther. 235:282-286; 1985.